Add time:07/18/2019         Source:sciencedirect.com

BackgroundHuman herpesvirus-6 (HHV-6) has been associated with a wide spectrum of diseases. (r)-9-[4-Hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) is an acyclic guanosine analogue that is structurally similar to acyclovir and is in clinical development for treatment of herpesvirus infections. H2G has been found to have activity against HSV type 1, HSV type 2, and HHV-6 in lymphoblast cell lines. A new anti-viral duplex drug, 3′-azido-3′-deoxythymidylyl-(5′ → 2-O)-3-O-octadecyl-sn-glycerol (AZT–lipid–PFA), linking zidovudine (AZT) and foscarnet (PFA) via a lipophilic octadecylglycerol residue (lipid) also exhibits anti-viral activities against HIV, HSV type 1 and HCMV.

We also recommend Trading Suppliers and Manufacturers of 9-(4-hydroxy-2-(hydroxymethyl)butyl)guanine (cas 105868-85-7). Pls Click Website Link as below: cas 105868-85-7 suppliers